Literature DB >> 17512354

Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes.

David A Morrow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17512354     DOI： 10.1016/j.jacc.2007.03.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

Authors:  David A Morrow; Marc S Sabatine; Marie-Luise Brennan; James A de Lemos; Sabina A Murphy; Christian T Ruff; Nader Rifai; Christopher P Cannon; Stanley L Hazen
Journal:  Eur Heart J       Date:  2008-03-12       Impact factor: 29.983

Review 2.  Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.

Authors:  Valentina Loria; Ilaria Dato; Francesca Graziani; Luigi M Biasucci
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

3.  Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.

Authors:  Michelle L O'Donoghue; David A Morrow; Christopher P Cannon; Petr Jarolim; Nihar R Desai; Matthew W Sherwood; Sabina A Murphy; Robert E Gerszten; Marc S Sabatine
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.